戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ents had a large dominant tumor (4 cm in the pancreatic head).
2 ial phase axial CT image at the level of the pancreatic head.
3 d by SRS and the majority are located in the pancreatic head.
4 he bile duct at the porta hepatis and in the pancreatic head.
5  severe chronic pancreatitis centered in the pancreatic head.
6 ial phase axial CT image at the level of the pancreatic head.
7 or patients with an inflammatory mass of the pancreatic head.
8  patients undergoing ST-PD versus AFA-PD for pancreatic head adenocarcinoma and other periampullary t
9 gible patients were those who presented with pancreatic head adenocarcinoma and periampullary tumors
10 atients with clinical stage I or II resected pancreatic head adenocarcinoma.
11 it compared with UR in early-stage, resected pancreatic head adenocarcinoma.
12 d the presence of a 1.2 x 2 cm lesion in the pancreatic head and a liver metastatis.
13         Histopathological examination of the pancreatic head and corpus at day 7 revealed less edema
14       It is recommended for continued use in pancreatic head and gallbladder cancers but not in ampul
15 eatic MCNs for which risks include male sex, pancreatic head and neck location, larger MCN, solid com
16 er pancreaticoduodenectomy for tumors of the pancreatic head and periampullary region.
17 of complex surgical procedures involving the pancreatic head and root of mesentery.
18 ign and low-grade malignant neoplasms in the pancreatic head and uncinate process between January 200
19                                      REn for pancreatic head and uncinate process tumors improved cli
20     Diagnostic categories were cancer of the pancreatic head and uncinate process, cancer of the body
21 d MR imaging: Most are small, located in the pancreatic head, and enhance homogeneously.
22                       Local resection of the pancreatic head appears to offer best outcomes and lowes
23 denum from the uncinate process and adjacent pancreatic head areas or the entire gland.
24 s of well-preserved tissue sections from the pancreatic head, body, and tail of organ donors with T1D
25     Three regions of interest were selected (pancreatic head, body, and tail) to obtain iodine concen
26                     PDFF was assessed in the pancreatic head, body, and tail.
27  benefit compared with standard resection in pancreatic head cancer.
28 a were analyzed for patients with stage I/II pancreatic head cancers treated from 2004 to 2009.
29       Among 57 patients, 32 were men; 42 had pancreatic head cancers.
30  cholera toxin B (CTB) was injected into the pancreatic head (CTB-488) and tail (CTB-555) of adult ma
31 ng management strategies in a patient with a pancreatic head cyst radiographically suggestive of BD-I
32 atients with localized adenocarcinoma of the pancreatic head deemed resectable on the basis of radiog
33 argin status for survival after resection of pancreatic-head ductal adenocarcinoma.
34 y curative therapy for adenocarcinoma of the pancreatic head during a 5-year period.
35     Fifteen (52%) tumors were located in the pancreatic head; eight (28%), in the tail; and six (21%)
36                    Patients with PDAC of the pancreatic head expected to undergo venous reconstructio
37 y or a Frey-procedure in case of an enlarged pancreatic head (>/=4 cm).
38 sectable at presentation than lesions in the pancreatic head, have similar postresection survival.
39 adenocarcinoma and a low-density mass in the pancreatic head identified by computed tomography (CT) r
40                 The tumor was located at the pancreatic head in 7 patients and the body/tail in 26 pa
41  the authors and others for resection of the pancreatic head in this disease, but distal pancreatecto
42  severe chronic pancreatitis centered in the pancreatic head, intractable abdominal pain, and a main
43        Surgical procedures for tumors of the pancreatic head involve time-consuming manual dissection
44  The presence of an inflammatory mass in the pancreatic head larger than 4 cm (P < 0.001), presence o
45 ere black, were on Medicare or Medicaid, had pancreatic head lesions, earned lower annual incomes, or
46 arily obstructive cholelithiasis (22.8%) and pancreatic head masses (13.9%).
47 mm (average 12.8 mm) and were located in the pancreatic head (n=7), body (n=2), tail (n=3) and uncina
48 table, 25.5% locally advanced, and 83.2% had pancreatic head/neck tumors.
49 sociated with splanchnic vein thrombosis and pancreatic head necrosis.
50         Local resection or excavation of the pancreatic head offers the advantage of lowest cost and
51  66 years; range, 39-86 years; 105 men) with pancreatic head or periampullary carcinoma were included
52 l SMV, cancers in the inferior aspect of the pancreatic head or root of mesentery (mid gut carcinoid)
53 tudy group] vs 2.89 +/- 0.33 [control group, pancreatic head]; p = 0.03; 2.2 +/- 0.92 [study group] v
54 elopment were splanchnic vein thrombosis and pancreatic head parenchymal necrosis.
55                   Macroscopic cancers of the pancreatic head presented regularly with common bile duc
56 was significantly greater innervation of the pancreatic head relative to the tail.
57 found to be better after duodenum-preserving pancreatic head resection (DPPHR) than after partial pan
58 ancreatoduodenectomy and duodenum-preserving pancreatic head resection are safe treatment options.
59 ancreatoduodenectomy and duodenum-preserving pancreatic head resection for chronic pancreatitis.
60 ificantly shorter in the duodenum-preserving pancreatic head resection group.
61 reaticoduodenectomy or a duodenum-preserving pancreatic head resection in our department between 2014
62 ead resection may favour duodenum-preserving pancreatic head resection in recommended diagnoses.
63                                              Pancreatic head resection in selected patients with chro
64 bolic dysfunctions after duodenum-preserving pancreatic head resection may favour duodenum-preserving
65 thout duct drainage, and duodenum-preserving pancreatic head resection offer outcomes as effective as
66                          Duodenum-preserving pancreatic head resection showed a statistically signifi
67      The mortality after duodenum-preserving pancreatic head resection was 0%.
68                          Patients undergoing pancreatic head resection with pancreaticojejunal anasto
69 ch as pancreaticojejunostomy with or without pancreatic head resection, which may provide better pain
70 ollowing types of resections were performed: pancreatic head resections [n = 77 (75%)], tail resectio
71 PJ], 29 distal pancreatectomies [DP], and 46 pancreatic head resections [PHR; 14 performed after fail
72 icoduodenectomies and 23 duodenum-preserving pancreatic head resections were performed.
73 eaticoduodenectomy for adenocarcinoma of the pancreatic head resulted in similar treatment toxicity,
74                                Patients with pancreatic head tumors (n = 388) had a median survival o
75  all patients and survival for patients with pancreatic head tumors were the primary end points.
76 rostomy is a standard surgical procedure for pancreatic head tumors, duodenal tumors and distal chola
77  A gastrin-producing islet cell tumor of the pancreatic head was also present.
78                                          The pancreatic head was involved in 74 patients (64%), follo
79 y resectable localized adenocarcinoma of the pancreatic head were entered onto a preoperative protoco
80 c pancreatitis with inflammatory mass in the pancreatic head were randomly assigned in 2 treatment gr
81 x patients with ductal adenocarcinoma of the pancreatic head were treated by regional subtotal or tot
82                       Local resection of the pancreatic head, with or without duct drainage, and duod